 price
deterior debat
anoth typic print continu
out-performance revenu highlight ortho
neurotech particularli pleas see mako
placement acceler doubl digit print knee implant
growth firmli establish domin share gainer
ljr larg joint recon neurotech crush
way put put take
segment spine focu thought trauma
extrem tad light endoscopi come well
margin execut in-line ep beat
aid lower expens materi qoq
step driven higher interest incom cash
balanc increas due euro debt rais still
cant explain qoq delta revenue guidanc st
mid-point investor unlik pay attent
notori conserv start year ep came
st model main driver seem line
driver lower expens benefit point
stood us poor convers step
note
acquisit relat cost invest work cap
culprit think like back focu average past
year well med-tech peer given
tweak pt lower equat price-to-earnings
adjust convers in-line
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
initi organ growth
price hw
initi ep
tax
neutral ep
would miss target still show omx
mako mean procedur total procedur
robot global us nearli robot global us instal base
robot japan launch
endo strong video product suction irrig boom light biz
ortho strong australia canada eu
medsurg strength came wast management smoke evac
medic benefit strength bed busi
neurotech spine driven hemorrhag ischem stroke well neuro power instrument sonopet iq
gm benefit acquisit fx off-set price mix
growth broad-bas
extra day
extra day vs
rest year day
bn debt rais
total bn
pipelin strong
deal annual support growth
earli comment coronaviru
sale forc momentum encourag acceler
em strong dd
best quarter far
center graviti organ heavili weight individu segment
 d/sale force/ etc discret
readi eu mdr
alreadi optim portfolio
continu tuck-in post even leverag need come
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin januari
analyst jon bristow vijay kumar primarili respons prepar research report attest follow view
opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
